Aim To evaluate patients' satisfaction with the adverse drug reactions (ADR) warning card model used within a metropolitan hospital network in Melbourne, Australia. Methods and Results A cross‐sectional survey, with interviewer‐administered questionnaire, of patients who experienced an ADR was conducted. Of the 241 eligible cases reviewed by the adverse drug reaction committee between January 2013 and April 2016, 45% (108) consented to a phone interview with 82% (89) recalling the ADR event. Of these, 55% (49) recalled receiving a temporary ADR warning card and 73% (65) remembered receiving a permanent ADR warning card post‐discharge. The ADR warning card was carried by 75% (67) of participants. It was found that 85% (76) had informed their doctor of the ADR while 40% (36) had informed their regular community pharmacist. Overall satisfaction was high with 89% (79) agreeing that this ADR service was valuable to them. Conclusion Overall, there was a high level of satisfaction, which supports the ADR warning card model as a model of care for patients who experience ADRs. In addition to informing the patient and their general practitioner about ADRs, consideration should be given to routinely informing their community pharmacists.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: